C

로킷헬스케어

376900KOSDAQ의료용품 및 기타 의약 관련제품 제조업

52.2 / 100

Reference Date: 2026-06-10

Financial Score19.0 / 40
News Sentiment18.2 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk. Plunged 27.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Rocket Healthcare develops a customized treatment platform integrating AI-based wound modeling, personalized bioinks, and 3D bioprinting technologies for regenerative medicine fields such as diabetic foot ulcers, chronic wounds, cartilage regeneration, and kidney treatments. The company focuses on addressing the growing demand driven by aging populations and chronic diseases, as well as the limitations of existing treatments.

Number of Employees

90people

Average Salary

7.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 19.194.0Point
PBR
Industry Average 1.303.5Point
ROE
Industry Average -4.893.5Point
Debt Ratio
24.83Industry Average 6.860.0Point

3.6x industry avg (risky)

Trend 2023~20258.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲52.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲66.3% (2-year basis)

ROE Trend
2.0 / 4

Detailed News Sentiment

21 totalPositive 15Neutral 3Negative 3Average Sentiment Score 72.9

Detailed Momentum

52-week position3.0Point

52w lower range (26%)

Current 49,550Won52-week high 147,90052-week low 13,770
1-month return0.0Point

1m -27.56% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

9 totalPositive 0Neutral 9Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-05-21
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-21
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-21
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-21
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-21